palivizumabAbrysvoPfizerbronchiolitislower respiratory tract infectionsRespiratory syncytial viruslower respiratory tract infectionantenatal education
… 2022, prevention was limited to the costly monoclonal antibody palivizumab. In August 2024, the UK introduced the RSVpreF (Abrysvo, Pfizer…